Skip to main content
. 2019 Jun 28;9:563. doi: 10.3389/fonc.2019.00563

Figure 6.

Figure 6

Correlation between IL-35 expression assessed by immunohistochemistry and the outcome of DLBCL patients. Distribution of age-adjusted international prognosis index (aa IPI) scores (A) and percentage (y-axis) of progression-free survival over time (x-axis) (Kaplan-Meier survival curves) of R-CHOP-treated DLBCL patients (B) classified into “IL-35-positive” and “IL-35-negative” by immunohistochemistry.